
Sign up to save your podcasts
Or


In this episode, Healthcare Research Analyst Luyi Guo shares her perspective on proposed pharmaceutical tariffs and drug pricing reform, including how they might spur innovation over the long run.
By Janus Henderson Investors4.7
1414 ratings
In this episode, Healthcare Research Analyst Luyi Guo shares her perspective on proposed pharmaceutical tariffs and drug pricing reform, including how they might spur innovation over the long run.

523 Listeners

965 Listeners

4,349 Listeners

1,936 Listeners

292 Listeners

653 Listeners

2,115 Listeners

1,296 Listeners

6,095 Listeners

9,927 Listeners

1,569 Listeners

449 Listeners

209 Listeners

78 Listeners

0 Listeners

3 Listeners